Biological warfare defense vaccine research and development program: hearing before the Subcommitttee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, October 23, 2001, 4권U.S. Government Printing Office, 2002 - 129페이지 |
기타 출판본 - 모두 보기
자주 나오는 단어 및 구문
American anthrax vaccine antibiotics antigen AVANT bacteria biodefense biological defense biological warfare BioPort biotechnology industry bioterrorism biowarfare Chairman cholera Christopher Shays Cipro clinical trials committee companies Congressman currently defense vaccines Department of Defense disease doses drugs efficacy EluSys evaluate FAUCI FDA approved filter changes going Heteropolymer HHS Readiness human immune inspect issue KINGSBURY KUCINICH LANTOS licensed manufacturing practices manufacturing process Michigan facility million National Security October 23 panel pathogens Phase post-marketing potential preparedness President protective antigen public health system PUTNAM question Readiness and Role require Research and Development response Role in Vaccine RYAN safety SANDERS Secretary THOMPSON September 11th SHAYS smallpox vaccine stockpile studies Subcommittee on National SUDOVAR surveillance talked terrorist testimony testing Thank therapeutics there's things TIERNEY toxin tularemia USAMRIID vaccine production Vaccine Research virus viruses WELDON WINEGER
인기 인용구
30 페이지 - I will be happy to answer any questions which you or members of the Subcommittee may have.
1 페이지 - The dogmas of the quiet past are inadequate to the stormy present. The occasion is piled high with difficulty, and we must rise with the occasion. As our case is new, so we must think anew and act anew. We must disenthrall ourselves, and then we shall save our country.
22 페이지 - In some cases, new vaccines, antitoxins, or innovative drug treatments need to be developed, manufactured, and/or stocked. Moreover, we need to learn more about the pathogenesis and epidemiology of the infectious diseases which do not affect the US population currently. We have only limited knowledge about how artificial methods of dispersion may affect the infection rate, range of illness, and public health impact of these biological agents.
70 페이지 - BEFORE THE SUBCOMMITTEE ON NATIONAL SECURITY, VETERANS AFFAIRS AND INTERNATIONAL RELATIONS, HOUSE COMMITTEE ON GOVERNMENT REFORM ON THE STANDARD PROCUREMENT SYSTEM FEBRUARY 7, 2002 Mr.
75 페이지 - Products: Evidence needed to Demonstrate Efficacy of New Drugs for Use Against Lethal or Permanently Disabling Toxic Substances When Efficacy Studies in Human Ethically Cannot be Conducted'.
100 페이지 - US states and 33 other nations. BIO members are involved in the research and development of health care, agricultural, industrial and environmental biotechnology products.
71 페이지 - during the dependent's annual trip between the school and the member's duty station" and inserting "one time per fiscal year". SEC. 544. MODIFICATION OF PROHIBITION ON REQUIREMENT OF NONAVAILABILITY STATEMENT OR PREAUTHORIZATION. Section 721 of the Floyd D. Spence National Defense Authorization Act for Fiscal Year 2001 (Public Law 106-398; 114 Stat.
12 페이지 - Department and other agencies to support and encourage research to address scientific issues related to bioterrorism. The capability to detect and counter bioterrorism depends to a significant degree on the state of relevant medical science.
90 페이지 - Steele L. Prevalence and patterns of Gulf War Illness in Kansas veterans: association of symptoms with characteristics of person, place and time of military service.
107 페이지 - Before the US House of Representatives Committee on Government Reform Subcommittee on National Security, Veterans...